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Remodelling of the human embryo at implantation is indispensable for 
successful pregnancy. Yet it has remained mysterious because of the 
experimental hurdles that beset the study of this developmental phase. 
Here, we establish an in vitro system to culture human embryos through 
implantation stages in the absence of maternal tissues and reveal the 
key events of early human morphogenesis. These include segregation 
of the pluripotent embryonic and extra-embryonic lineages and 
morphogenetic re-arrangements leading to: generation of a bi-laminar 
disc, formation of a pro-amniotic cavity within the embryonic lineage, 
appearance of the prospective yolk sac, and trophoblast differentiation. 
Using human embryos and human pluripotent stem cells, we show that 
the reorganisation of the embryonic lineage is mediated by cellular 
polarisation leading to cavity formation. Together, our results indicate 
that the critical remodelling events at this stage of human development 
are embryo-autonomous highlighting the remarkable and unanticipated 
self-organising properties of human embryos.	
	
Introduction		The	development	of	a	human	embryo	from	a	fertilized	egg	begins	with	a	series	of	cleavage	divisions	and	morphogenetic	rearrangements	that	lead	to	the	formation	of	 a	 free-floating	 blastocyst.	 This	 blastocyst	 comprises	 three	 distinct	 cell	lineages:	 embryonic	 tissue	 (epiblast)	 and	 two	 extra-embryonic	 tissues	(hypoblast	and	trophectoderm)	that,	after	implantation	into	the	uterus,	will	give	rise	to	the	yolk	sac	and	placenta	respectively.	This	pre-implantation	period	has	been	 extensively	 studied	 using	 methods	 that	 pioneered	 in	 vitro	 fertilization	(IVF)1,	 2.	 However,	 on	 the	 7th	 day	 of	 development,	 the	 human	 embryo	 must	implant	into	the	uterus	of	the	mother	to	survive,	establish	the	body	plan	and	to	generate	the	germ	layers.	The	failure	of	an	embryo	to	implant	is	a	major	cause	of	early	pregnancy	loss3	and	yet	the	cellular	and	molecular	changes	that	take	place	in	the	human	embryo	at	this	stage	remain	unknown.	This	is	because	experiments	
in	vivo	are	not	feasible	and	there	has	been	no	system	to	culture	human	embryos	
ex	vivo.			
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Monkey	embryos	have	been	used	as	a	model	for	human	embryo	development4,	5	and	the	co-culture	of	human	blastocysts	and	endometrial	cells6	has	provided	an	experimental	 system	 to	model	post-implantation	morphogenesis.	However,	 the	extent	to	which	these	systems	recapitulate	post-implantation	development	of	the	human	 embryo	 remains	 an	 open	 question.	 Moreover,	 the	 potential	 of	 human	blastocysts	for	self-organisation	has	never	been	explored.		Here,	to	shed	light	on	the	early	post-implantation	phases	of	human	development,	we	 have	 adapted	 our	 recently	 established	 protocol	 for	mouse	 embryos7,	8.	 The	culture	system	we	have	established	allows	human	embryos	to	undergo	the	pre-	to	post-implantation	 transition	 in	vitro,	 in	 the	absence	of	 any	maternal	 tissues.	By	comparing	human	embryos	developing	 in	vitro	and	the	Carnegie	series	of	 in	
vivo	 developing	human	embryos9,	we	have	 identified	 that	 the	key	hallmarks	of	human	 embryogenesis	 take	 place	 in	 the	 absence	 of	 any	 maternal	 tissues,	uncovering	the	self-organising	properties	of	human	embryos	at	this	stage.			
	
Results	
Establishment	 of	 a	 method	 to	 culture	 human	 embryos	 through	
implantation	stages	in	vitro	In	order	 to	gain	understanding	of	 the	developmental	events	undertaken	by	 the	implanting	 human	 embryo,	 we	 reasoned	 that	 we	 needed	 an	 in	 vitro	 culture	system	 that	 would	 recapitulate	 these	 processes.	 To	 this	 end,	 we	 adapted	 the	culture	 conditions	 we	 had	 previously	 established	 for	 mouse	 embryos	 at	comparable	stages7.	Supernumerary	pre-implantation	human	embryos	(at	either	cleavage	or	blastocysts	stage)	donated	for	this	project	were	thawed	and	placed	in	culture	medium	to	recover,	before	the	zona	pellucida	was	removed	(Methods).	Embryos	 were	 scored	 by	 morphological	 criteria	 and	 those	 showing	abnormalities	 (fragmented	 blastomeres	 or	 developmentally	 arrested)	 were	discarded.	We	first	plated	human	blastocysts	on	optical	grade	dishes	in	21%	O2	and	in	 in	vitro	culture	medium	1	(IVC1)	which	was	replaced	by	IVC2	after	48h7	(Fig.	1a,	b).	Time-lapse	microscopy	revealed	that	human	blastocysts	cultured	in	IVC1	underwent	a	series	of	contractions	and	expansions	reflecting	collapse	and	subsequent	 enlargement	 of	 the	 blastocyst	 cavity	 (Supplementary	 Video	 1),	 as	
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observed	 in	 IVF	 clinics10.	 However,	 by	 the	 end	 of	 day	 7,	 the	 blastocyst	 cavity	completely	collapsed	and	embryos	attached	to	the	dish	(Fig.	1b-d).	At	this	time	the	attached	embryos	started	to	grow	and	this	growth	continued	until	day	12-13	(Fig.	1c,	d	and	Supplementary	Video	2).	We	previously	found	that	either	human	cord	serum	(HCS)	or	KnockOut	Serum	Replacement	(KSR)	in	IVC2	permits	peri-implantation	mouse	development11.	Human	embryos	also	developed	with	either	supplement	 up	 to	 day	 13	 (Fig.	 1d).	 The	 experiment	was	 stopped	 at	 this	 point	because	the	internationally	recognized	ethical	limit	for	human	embryo	culture	is	up	to	day	14	or	to	the	first	signs	of	development	of	the	primitive	streak12.		The	trend	 in	 IVF	clinics	over	recent	years	has	been	to	culture	pre-implantation	human	embryos	in	hypoxic	conditions	(5%	O2),	as	this	favors	embryo	survival13	and	inhibits	differentiation	in	embryonic	stem	cells14,	15.	To	investigate	whether	hypoxic	 conditions	 offer	 any	 advantage	 to	 human	 embryos	 cultured	 through	implantation,	we	compared	development	of	embryos	cultured	in	21%	O2	to	ones	cultured	 in	5%	O2	 in	 terms	of	preservation	of	 the	pluripotent	 lineage.	 Initially,	day	5-6	pre-implantation	blastocysts	had	a	 group	of	 inside	pluripotent	 cells	 as	indicated	by	the	presence	of	the	transcription	factor	OCT4	(Fig.	2a,	b).	However,	after	 4	 days	 in	 culture,	 whereas	 49%	 of	 embryos	 (N=59)	 cultured	 in	 21%	 O2	maintained	 a	 cluster	 of	 epiblast	 cells	 showing	 expression	 of	 the	 pluripotency	factor	 OCT4,	 none	 of	 the	 embryos	 cultured	 in	 hypoxic	 conditions	 (N=20)	 had	OCT4-expressing	cells		(Supplementary	Table	1).	In	contrast,	cells	of	embryos	in	hypoxic	 conditions	 displayed	 signs	 of	 cell	 death	 (Fig.	 2c).	 This	 suggests	 that	preservation	of	the	epiblast	 in	vitro	beyond	day	7	might	benefit	 from	higher	O2	concentrations	 possibly	 because	 of	 the	 increase	 in	 embryo	 size,	 which	 may	decrease	 the	 O2	 pressure	 in	 the	 core	 of	 the	 embryo.	 Hypoxia	 clearly	 has	 a	complex	 influence	on	embryonic	development	and	 its	effects	need	 to	be	better	understood	 in	 the	 intrauterine	milieu	 to	 determine	 exactly	 how	 it	 affects	 both	mouse	 and	 human	 embryogenesis16.	 As	 a	 result	 of	 these	 findings,	 here	 we	cultured	 human	 embryos	 beyond	 day	 7	 in	 21%	 O2,	 which	 we	 show	 permits	further	development	of	the	pluripotent	lineage	in	vitro.		
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Development	 of	 the	 embryonic	 and	 extra-embryonic	 lineages	 during	
human	post-implantation	morphogenesis	in	vitro	To	 gain	 temporal	 understanding	 of	 the	 cellular	 and	 developmental	 events	through	 early	 post-implantation	 development,	 we	 fixed	 and	 immunostained	human	embryos	at	different	time	points	of	culture.	We	used	KSR	to	supplement	the	medium	as	it	permits	a	more	reproducible	time	course	of	development	than	HCS7.	We	 have	 focused	 on	 development	 between	 days	 7	 and	 11,	 since	 during	these	5	days	the	embryo	undergoes	a	major	reorganisation	that	is	necessary	for	subsequent	gastrulation9.	Shortly	after	attachment	(day	7-8	of	development),	we	observed	a	clear	separation	between	embryonic	(OCT4-expressing,	epiblast)	and	extra-embryonic	(GATA6-expressing,	hypoblast)	cells,	the	respective	progenitors	for	 the	 fetus	and	yolk	sac	 (Fig.	3a),	whereas	 in	 the	unattached	blastocysts,	 this	segregation	of	epiblast	and	hypoblast	progenitors	had	not	yet	 taken	place	 (Fig.	2b).	 This	 contrasts	 to	 mouse	 embryos,	 where	 the	 epiblast	 and	 the	 hypoblast-equivalent	 (the	 primitive	 endoderm)	 segregate	 already	 before	 implantation17;	but	agrees	with	observations	 in	human	embryos18-22.	We	found	that	at	day	7-8,	the	 epiblast	 was	 formed	 by	 a	 cluster	 of	 about	 20	 OCT4-expressing	 cells	surrounded	by	approximately	50	GATA6-expressing	hypoblast	cells	(Fig.	3a,	and	Supplementary	 Table	 2).	 By	 day	 8-9,	 GATA6-expressing	 hypoblast	 cells	preferentially	localized	to	one	side	of	the	epiblast,	as	occurs	in	human	embryos	developing	 in	 vivo9.	 This	 spatial	 organisation	 was	 maintained	 throughout	subsequent	developmental	stages	(from	day	9	to	day	11)	(Fig.	3a,	Supplementary	Fig.	 1a	 and	 Supplementary	 Videos	 3	 and	 4).	 By	 day	 11,	 the	 number	 of	 OCT4-expressing	 epiblast	 cells	 had	 significantly	 increased	 to	 an	 average	of	 328	 cells,	whereas	 the	 number	 of	 GATA6-expressing	 hypoblast	 cells	 increased	 up	 to	 79	(Supplementary	Table	2).			To	analyse	development	of	 trophectoderm,	 the	progenitors	of	 the	placenta,	we	followed	 cytokeratin	 7	 (CK7),	 which	 is	 highly	 expressed	 in	 trophoblast	derivatives23.	We	 found	 that	 the	 trophectoderm	 cells	 surrounding	 the	 epiblast	and	hypoblast	(Fig.	3b)	presented	a	polarised	epithelial	phenotype,	evident	from	the	 localization	of	 the	apical	determinant	PAR6	(Fig.	3c).	From	day	8	onwards,	we	noted	the	presence	of	CK7-expressing	multinucleated	cells	 in	the	outermost	
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region	of	the	embryo	(Fig.	3d).	To	determine	their	exact	position	with	respect	to	the	 epiblast-hypoblast	 cluster,	 we	 performed	 a	 3D	 reconstruction	 of	 cellular	shapes,	based	on	the	computational	segmentation	of	membranes	and	nuclei	(Fig.	3e).	This	revealed	two	trophectoderm	subpopulations:	cells	 in	proximity	to	 the	epiblast-hypoblast	bilayer	had	a	single	nucleus,	whereas	those	in	the	periphery	of	the	embryo	were	multinucleated	and	displayed	characteristic	lacunae	(Fig.	3e	and	Supplementary	Video	5).	Based	on	the	expression	of	CK7,	their	position	and	their	 cellular	 and	 nuclear	 shape,	 these	 two	 cell	 populations	 are	 likely	 to	correspond	 to	 the	 cytotrophoblast	 and	 syncytiotrophoblast	 respectively,	indicating	 that	 development	 post-implantation	 trophoblast-derivatives	 can	 be	recapitulated	 in	 the	 absence	 of	 any	 maternal	 tissue.	 	 Together	 these	 results	demonstrate	 that	 the	 development	 of	 all	 three	 lineages	 progresses	 as	 human	embryos	develop	in	vitro.		
Human	epiblast	polarisation	and	pro-amniotic	cavity	formation		Next,	we	focused	on	the	development	of	the	epiblast	since	it	undergoes	its	first	major	 reorganisation	 at	 implantation.	 One	 of	 the	 hallmarks	 of	 epiblast	transformation	is	the	acquisition	of	a	polarised	phenotype	and	the	formation	of	a	lumen,	 the	 prospective	 pro-amniotic	 cavity9,	 24,	 essential	 for	 the	 subsequent	development	 of	 the	 body	 plan.	 However,	 the	 cellular	 mechanisms	 underlying	lumen	 formation	 in	humans	currently	remain	unknown.	While	some	reports	 in	higher	primates	point	towards	cell	death	within	the	epiblast	as	the	major	driver	of	 lumen	 formation25,	 alternative	 reports	 suggest	 folding	of	 the	 epiblast26,	 or	 a	change	of	polarity	in	epiblast	cells4.	Importantly,	these	hypotheses	are	based	on	the	observations	of	Rhesus	monkey	embryos	by	electron	microscopy	as	to	date	it	has	 not	 been	 possible	 to	 definitively	 identify	 cell	 types	 and	 their	 features	 in	human	embryos	at	 implantation.	We	found	that	at	day	7-8	of	development,	 the	epiblast	 was	 a	 cluster	 of	 cells	 showing	 no	 signs	 of	 polarisation	 (Fig.	 4a,	Supplementary	Fig.	1b	and	2).	However,	by	day	8-9,	a	group	of	OCT4-expressing	epiblast	 cells	 became	 radially	 organised	 around	 a	 small	 central	 lumen.	 These	cells	were	apico-basally	polarised	in	31%	of	the	embryos	(Supplementary	Table	1),	 as	 determined	 by	 the	 polarised	 apical	 localization	 of	 actin	 and	 aPKC	 (the	principal	kinase	of	the	apical	Par	polarity	complex)	(Fig.	4a	and	Supplementary	
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Fig.	 1b).	 The	 formation	 of	 a	 small	 lumen	 at	 the	 exact	 site	 of	 incipient	 apical	polarisation	 indicates	 the	 onset	 of	 pro-amniotic	 cavity	 formation	 within	 the	epiblast.	 Importantly,	we	 did	 not	 observe	 any	 apoptotic	 cell,	 cellular	 debris	 or	any	 other	 indication	 of	 cell	 death	 in	 the	 incipient	 pro-amniotic	 cavity	(Supplementary	 Fig.	 3).	 These	 results	 indicate	 that	 the	 epiblast	 becomes	polarised	by	day	9	of	in	vitro	development	and	suggest	that	apoptosis	is	not	the	mechanism	driving	lumenogenesis	in	human	embryos.			
Human	bi-laminar	disc	formation		The	next	expected	remodelling	event	is	the	formation	of	the	amniotic	epithelium	and	the	epiblast	disc.	In	contrast	to	the	mouse,	in	which	the	amnion	is	formed	at	gastrulation,	 the	 amnion	 is	 expected	 to	 form	 in	 humans	 shortly	 after	implantation	 with	 those	 epiblast	 cells	 adjacent	 to	 the	 hypoblast	 acquiring	 a	columnar	 shape,	 and	 those	 in	 contact	with	 cytotrophoblast	 differentiating	 into	squamous	and	 flat	amniotic	epithelium.	At	 this	stage,	both	 tissues	 line	 the	pro-amniotic	 cavity24.	We	observed	 that	 as	 development	 of	 embryos	progressed	 in	
vitro,	 the	 epiblast	 and	 the	pro-amniotic	 cavity	 expanded	 in	 size	 (Fig.	 4a	 and	b,	Supplementary	 Fig.	 4,	 Supplementary	 Table	 2	 and	 Supplementary	 Video	 6)	indicative	of	embryo	growth.	At	day	10-11	of	development,	we	could	detect	two	morphologically	distinct	groups	of	OCT4-expressing	cells.	3D	reconstructions	of	cellular	 shapes	 revealed	 that	OCT4-expressing	 cells	 located	near	 the	hypoblast	had	a	columnar	morphology	whereas	opposite-facing	OCT4-expressing	cells	had	a	 distinct	 squamous	 and	 flat	 shape	 (Fig.	 4c	 and	 Supplementary	 Video	 7).	Moreover,	these	flat	OCT4-expressing	cells	were	in	close	proximity	to	cells	with	a	higher	nuclear	volume	(on	average	2.5	times	bigger	than	epiblast	cells),	a	feature	characteristic	of	trophoblast	cells.	These	observations	suggest	that	the	two	types	of	 OCT4-expressing	 cells	 may	 represent	 the	 epiblast	 disc	 and	 the	 prospective	amniotic	epithelium.		
Human	prospective	yolk	sac	formation	The	next	expected	event	of	human	embryo	development	is	the	reorganisation	of	hypoblast	cells	to	give	rise	to	a	second	cavity,	the	primary	yolk	sac9,	27,	which	will	provide	 the	 blood	 supply	 to	 the	 developing	 fetus.	 Remarkably,	 we	 found	 that	
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human	 embryos	 developing	 in	 vitro	 established	 a	 second	 cavity	 at	 day	 11	 of	development	 (Supplementary	 Video	 8).	 This	 cavity	 was	 localized	 below	 the	epiblast	 and	 was	 surrounded	 by	 GATA6-expressing	 cells,	 highlighting	 its	hypoblast	origin	(Fig.	4d,	e	and	Supplementary	Video	9).	Thus,	both	expression	of	characteristic	lineage	markers	as	well	as	morphological	features	suggest	that	formation	 of	 the	 prospective	 yolk	 sac	 can	 be	 also	 recapitulated	 in	 human	embryos	developing	in	vitro	(Fig.	4f).			
Human	 pluripotent	 stem	 cells	 (hPSCs)	 recapitulate	 the	 events	 of	
polarisation	and	lumenogenesis	Since	the	above	results	revealed	that	epiblast	polarisation	and	lumen	formation	are	 the	 first	 features	 of	 epiblast	 morphogenesis	 after	 implantation,	 we	 next	investigated	 the	molecular	 pathways	 that	 could	 be	 responsible	 for	 this	 critical	remodelling.	 Given	 the	 ethical	 restrictions	 and	 the	 limited	 number	 of	 human	embryos	 available	 for	 functional	 studies,	we	 turned	 to	human	embryonic	 stem	cells	(hESCs)	and	human	induced	pluripotent	stem	cells	(hiPSCs)	as	alternative	models.	 In	 order	 first	 to	 determine	 whether	 the	 extracellular	 matrix	 (ECM)	participates	in	inducing	epiblast	polarisation	and	lumen	formation,	we	cultured	individual	 hESCs	 in	 3D	 matrigel.	 We	 found	 that	 surrounding	 cells	 with	 ECM	enabled	 lumen	 formation	 by	 24h	 after	 cell	 plating,	 and	 so	 it	 was	 sufficient	 to	have	two	sister	cells	from	a	single	cell	division	for	this	to	take	place	(Fig.	5a),	in	agreement	with	other	 recent	observations28.	As	 the	hESCs	 continued	 to	divide,	they	self-organised	around	a	central	lumen.	These	hESCs-organoids	were	apico-basally	polarised,	as	demonstrated	by	the	polarised	localization	of	aPKC	(Fig.	5a),	PAR6	 (Fig.	 5b),	 centrosomes	 (Fig.	 5c)	 and	 the	 Golgi	 (Fig.	 5d).	 They	 retained	expression	 of	 pluripotency	 markers	 such	 as	 OCT4	 (Fig.	 5a),	 mimicking	 the	preservation	of	OCT4	in	the	epiblast	of	in	vitro	cultured	human	embryos	(Fig.	3).	To	confirm	these	results	we	next	plated	hiPSCs	into	3D	matrigel	as	we	did	with	hESCs.	We	found	that	hiPSCs	also	polarised	and	began	to	form	lumens	between	two	 cells,	 while	 retaining	 OCT4	 expression	 (Fig.	 6a).	 Lumens	 formed	 on	 the	apical	 side	 of	 polarised	 cells	 that	 displayed	 apical	 microvilli	 and	 a	 polarised	distribution	of	aPKC,	PAR6	and	the	Golgi	(Fig.	6a-c).	This	polarised	organisation	was	 preserved	 in	 the	 presence	 of	 the	 ROCK	 inhibitor	 Y-27632	 (Fig.	 6d),	
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commonly	used	to	avoid	cell	death	at	the	time	of	plating	of	hPSCs.	We	could	also	detect	 lumen-directed	 secretion	 of	 the	 anti-adhesive	 protein	 Podocalyxin	(PODXL),	 implicated	 in	 lumen	 formation	 through	charge-repulsion29,	30	 (Fig.	6e,	f).	 	The	observation	 that	hPSC-organoids	develop	 lumens	between	 two	 cells	 as	they	become	polarised,	 suggests	 that	 lumen	 formation	 is	 not	 a	 consequence	of	cell	 death.	 To	 test	 this	 possibility	 directly,	we	 treated	 hiPSCs	with	 a	 caspase	 3	inhibitor	to	prevent	cell	death8	and	found	that	polarisation	and	lumen	formation	were	 not	 affected	 (Fig.	 6g,	 h).	 Taken	 together	 our	 results	 indicate	 that	 lumen	formation	is	a	consequence	of	cellular	polarisation	and	not	cell	death	and	lead	us	to	suggest	that	similar	molecular	pathways	may	drive	lumenogenesis	 in	human	embryos	soon	after	implantation.			
Discussion	Implantation	is	a	milestone	in	human	development	as	this	is	the	time	when	the	embryo	undergoes	major	 remodelling,	which	 is	 absolutely	 required	 for	 correct	gastrulation	 and	 therefore	 successful	 body	 formation	 and	 pregnancy	 outcome.	However,	to	date,	the	absence	of	an	in	vitro	culture	system	to	visualise	and	model	this	critical	developmental	transition	has	severely	limited	our	understanding	of	human	 embryogenesis.	 Here,	 we	 have	 established	 a	 system	 for	 the	 in	 vitro	culture	 of	 human	 embryos	 that	 offers	 a	 unique	 opportunity	 to	 understand	human	development	after	 implantation.	This	system	has	allowed	us	to	uncover	the	 major	 morphogenetic	 events	 that	 normally	 occur	 after	 human	 embryo	implantation	 including:	 (i)	 epiblast	 and	 hypoblast	 segregation;	 (ii)	 epiblast	polarisation;	 (iii)	 formation	of	 the	pro-amniotic	 cavity	 and	 the	bi-laminar	disc;	(iv)	 appearance	 of	 the	 prospective	 amniotic	 ectoderm;	 (v)	 appearance	 of	 yolk	sac;	 and	 (vi)	 differentiation	 of	 the	 trophoblast	 into	 cytotrophoblast	 and	syncytiotrophoblast	 (Fig.	 4f).	 Although	 this	 system	 may	 not	 be	 able	 to	 fully	recapitulate	 all	 the	 complex	 aspects	 of	 human	 embryogenesis	 in	 vivo,	 it	 has	allowed	us	to	reveal	a	remarkable	self-organising	capacity	of	human	blastocysts	that	 has	 been	 previously	 unknown.	 The	 next	 stage	 in	 human	 development	corresponds	to	primitive	streak	formation	but	for	ethical	reasons	we	are	obliged	to	 stop	 our	 cultures	 at	 day	 14	 of	 development	 or	 before	 the	 primitive	 streak	
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formation12.	Thus,	our	studies	have	focused	on	the	key	events	of	pre-gastrulation	stages.		Our	results	 indicate	that	the	formation	of	the	pro-amniotic	cavity	in	the	human	embryo	 is	 not	 triggered	 by	 apoptosis,	 as	 hypothesised25,	 but	 by	 the	 epiblast’s	polarisation,	 as	 proposed	 in	 monkey	 embryos4.	 	 Because	 of	 the	 limitations	 to	perform	 functional	 studies	 in	 human	 embryos,	 we	 have	 used	 hPSCs	 as	 an	alternative	 model	 to	 test	 this	 hypothesis,	 and	 demonstrate	 that	 the	 ECM	participates	 in	 inducing	 cell	 polarisation	 and	 lumen	 formation	 via	 polarised	secretion	(hollowing)	and	not	programmed	cell	death	(cavitation).	This	is	similar	to	the	mechanism	of	epiblast	polarisation	we	have	recently	found	to	operate	 in	mouse	embryos8.	Thus,	remarkably,	despite	the	significant	differences	in	embryo	morphology	 between	 these	 different	 mammalian	 species,	 the	 initial	 steps	 of	post-implantation	embryogenesis	are	evolutionarily	conserved.		One	 of	 the	most	 intriguing	 aspects	 of	 human	 implantation	 development	 is	 the	differentiation	 of	 the	 epiblast	 into	 the	 epiblast	 disc	 and	 the	 amniotic	epithelium24.	 Interestingly,	we	could	not	recapitulate	 formation	of	 the	amniotic	epithelium	in	our	3D	hPSC	culture	possibly	because	this	developmental	process	requires	interaction	with	extra-embryonic	tissues	present	in	the	whole	embryo.	It	will	be	of	interest	to	determine	the	signalling	pathways	required	for	modelling	amnion	formation	in	vitro.	Indeed,	we	anticipate	that	future	studies	using	the	in	
vitro	 culture	 systems	we	 report	 here	 for	 both	 human	 embryos	 and	 hPSCs	will	shed	new	light	on	the	cellular	and	molecular	mechanisms	of	this	mysterious	and	yet	 critical	 stage	 of	 human	 development,	 which	 will	 be	 of	 basic	 and	 clinical	importance.	
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Figure	legends	
	
Figure	1	|	Establishment	of	an	in	vitro	system	to	study	human	implantation	
and	 early	 post-implantation	morphogenesis.	Human	 embryos	were	 thawed	and	 cultured	 until	 the	 blastocyst	 stage	 (day	 5-6	 of	 development).	 The	 zona	
pellucida	was	removed	and	embryos	were	transferred	to	plates	in	IVC1	medium	for	 imaging.	On	 the	 second	day	of	 culture,	medium	was	 changed	 for	 IVC2	with	30%	 KnockOut	 Serum	 Replacement	 (KSR)	 (b,	 c)	 or	 20%	 human	 cord	 serum	(HCS)	 (d).	 Shown	 are	 representative	 bright	 field	 images	 of	 human	 blastocysts	developing	 in	vitro	until	day	12-13.	All	scale	bars,	100	μm.	These	data	 involved	the	 assessment	 of	 a	 total	 of	 5	 embryos	 out	 of	 which	 3	 showed	 a	 correct	development.	Images	are	representative	of	3	experiments.			
Figure	 2	 |	 Preservation	 of	 the	 pluripotent	 lineage	 in	 human	 embryos	
cultured	through	implantation	stages	in	vitro.	a,	Bright	field	images	of	day	5-6	blastocysts.	Asterisks	indicate	the	inner	cell	mass.	b,	Day	5-6	blastocysts	were	fixed	 and	 immunostained	 for	 lineage	 markers.	 Representative	 confocal	 Z	sections	of	human	blastocysts	stained	for	OCT4	and	GATA6,	and	OCT4	and	CK7.	
c,	Human	embryos	cultured	in	either	21%	or	5%	O2	were	analysed	at	 indicated	time	 points.	 Representative	 confocal	 Z	 sections	 of	 human	 embryos	 stained	 for	OCT4,	 aPKC	 and	 F-actin.	 Note	 the	 absence	 of	 OCT4-expressing	 cells	 and	 the	presence	of	fragmented	nuclei	in	the	embryos	cultured	in	5%	O2.	All	scale	bar,	50	μm.		These	data	involved	the	assessment	of	a	total	of	59	embryos	in	21%	O2		(out	of	which	29	embryos	preserved	 the	epiblast)	and	20	embryos	 in	5%	O2	(out	of	which	none	preserved	the	epiblast).	Images	are	representative	of	3	experiments.		
	
Figure	3	 |	Analysis	 of	 embryonic	 and	 extra-embryonic	 lineages	 in	human	
embryos	 cultured	 through	 implantation	 stages	 in	 vitro.	 Human	 embryos	developing	in	vitro	until	day	11	were	fixed	and	stained	at	indicated	time	points.	
a,	Representative	confocal	Z	sections	of	 	human	embryos	stained	for	OCT4	and	GATA6.	Right	panels	show	the	centre	of	all	OCT4-expressing	(white)	and	GATA6-expressing	 (green)	 cells.	 All	 positive	 cells	 were	 counted	 regardless	 of	 the	fluorescence	 intensity	value.	b,	Representative	confocal	Z	section	of	a	day	9-10	
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embryo	stained	for	OCT4,	GATA6	and	CK7.	c,	Representative	confocal	Z	section	of	 a	 day	 8-9	 embryo	 stained	 for	 PAR6	 and	 CK7.	 d,	 Representative	 confocal	 Z	section	 of	 human	 embryos	 stained	 for	 F-actin	 and	 DAPI.	 Arrowheads	 point	 to	multinucleated	 cells.	e,	 3D	 reconstruction	 of	 the	 cellular	 and	 nuclear	 shape	 of	representative	 trophectoderm	 cells.	 Note	 that	 cells	 in	 close	 proximity	 to	 the	epiblast	have	a	single	nucleus,	whereas	cells	in	the	periphery	of	the	embryo	are	multinucleated.		All	yellow	squares	indicate	the	regions	in	the	embryos	that	are	shown	with	higher	magnification.	All	scale	bars,	50	μm.		These	data	involved	the	assessment	of	a	total	of	59	embryos	out	of	which	29	showed	preservation	of	the	embryonic	lineage.	Images	are	representative	of	6	experiments.			
Figure	4	|	Remodelling	of	the	epiblast	in	human	embryos	cultured	through	
implantation	 stages.	Human	 embryos	 developing	 in	 vitro	 until	 day	 11	 were	fixed	and	stained	at	indicated	time	points.	a,	Representative	confocal	Z	sections	of		human	embryos	stained	for	F-actin,	aPKC,	and	OCT4.	Arrowheads	indicate	the	incipient	 pro-amniotic	 cavity.	 b,	 3D	 reconstruction	 of	 the	 pro-amniotic	 cavity	(shown	in	red).	The	nuclei	of	OCT4-expressing	epiblast	cells	is	shown	in	gray.	c,	3D	 reconstruction	 of	 the	 cellular	 shape	 of	 representative	 OCT4-expressing	epiblast	cells.	d,	3D	reconstruction	of	 the	prospective	yolk	sac	(shown	in	blue).	The	 nuclei	 of	 OCT4-expressing	 epiblast	 cells	 is	 shown	 in	 gray.	 e,	 Day	 10-11	embryo	 stained	 for	 F-actin,	 OCT4,	 GATA6	 and	 aPKC.	 Note	 the	 presence	 of	GATA6-expressing	 cells	 on	 both	 sides	 of	 the	 cavity	 (arrowheads).	 The	prospective	yolk	sac	is	 indicated	with	a	dashed	line.	f,	Model	of	human	embryo	implantation	morphogenesis	based	on	our	results	and	 the	Carnegie	Series.	The	major	 remodelling	 events	 that	 take	 place	 during	 this	 transition	 are:	 (i)	segregation	 of	 epiblast	 and	 hypoblast	 progenitors	 -day	 7;	 (ii)	 polarisation	 and	pro-amniotic	cavity	formation	in	the	epiblast	-day	8-10;	(iii)	differentiation	of	the	trophectoderm	into	cytotrophoblast	and	syncytiotrophoblast	cells	-day	8-10;	(iv)	formation	of	 the	prospective	amniotic	epithelium,	 the	prospective	yolk	sac	and	the	 bilaminar	 disc–day	 10-11.	 All	 squares	 indicate	 the	 regions	 in	 the	 embryos	that	 are	 shown	 with	 higher	 magnification.	 All	 scale	 bars,	 50	 μm.		 These	 data	involved	 the	 assessment	 of	 a	 total	 of	 59	 embryos	 out	 of	which	 9	 showed	pro-amniotic	cavity	formation.	Images	are	representative	of	6	experiments.		
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Figure	 5	 |	 Self-organisation	 of	 hESCs	 in	 response	 to	 extracellular	 matrix	
signaling.	hESCs	 were	 plated	 in	 a	 3D	 matrix	 of	 matrigel	 and	 analysed	 at	 the	indicated	 time	 points.	a,	 hESCs	 stained	 for	 OCT4	 as	 a	marker	 of	 pluripotency,	aPKC	 as	 marker	 of	 apical	 polarisation	 and	 F-actin	 to	 reveal	 the	 general	organisation	of	the	cells.	b,	hESCs	stained	for	PAR-6	and	F-actin.	The	size	of	the	lumen	was	 quantified.	 Data	 is	 shown	 as	 average	 ±	 s.e.m.	 Note	 the	 increase	 in	lumen	size	with	time	(n=10	hESC	organoids	per	time	point).	Unpaired	two-tailed	Student’s	 t	 test	 with	 Welch’s	 correction,	 **p=0.0049.	 c,	hESCs	 stained	 for	 the	centrosome	 marker	 γ-Tubulin	 and	 F-actin.	 Arrowheads	 indicate	 the	 polarised	apical	localization	of	the	centrosome.	The	nucleus	centrosome	angle	with	respect	to	 the	 nucleus-nucleus	 axis	 is	 shown.	 Each	 dot	 represents	 an	 individual	centrosome.	 Data	 is	 shown	 as	 average	 ±	 s.e.m.	 (n=19	 centrosomes).	 d,		 hESCs	stained	 for	 the	 Golgi	 marker	 GM130	 and	 F-actin.	 Arrowheads	 indicate	 the	polarised	 apical	 localization	 of	 the	 Golgi.	 All	 scale	 bars,	 10	 µm. 	 These	 data	involved	 the	 assessment	 of	 a	minimum	 of	 10	 hESC	 organoids	 per	 panel,	 all	 of	which	showed	the	indicated	phenotype.	Images	are	representative	of	a	minimum	of	2	independent	experiments	per	panel.		
 
Figure	 6	 |	 Self-organisation	 of	 hiPSCs	 in	 response	 to	 extracellular	matrix	
signaling.	 hiPSCs	were	 plated	 in	 a	 3D	matrix	 of	matrigel	 and	 analysed	 at	 the	indicated	time	points.	a-b,	hiPSCs	stained	for	aPKC,	OCT-4	and	F-actin.	c,	hiPSCs	stained	for	PAR-6,	GM130	and	F-actin.		d,		hiPSCs	cultured	in	the	presence	of	the	ROCK	inhibitor	Y-27632	and	stained	for	aPKC	and	F-actin.	e-f,	hiPSCs	cultured	in	the	presence	(e)	or	absence	(f)	of	ROCK	inhibitor,	and	stained	for	PODXL	and	F-actin	g,	hiPSCs	were	treated	with	the	caspase	3	inhibitor	Z-DEVD	FMK	and	lumen	formation	was	analysed	24	and	48	hours	after	plating	by	staining	for	aPKC	and	F-actin.	h,	Quantification	of	lumen	formation	in	the	presence	of	Z-DEVD	FMK.	Data	is	shown	as	a	contingency	table.	Fisher’s	exact	test.	ns:	not	significant.	These	data	involved	the	assessment	of	a	minimum	of	10	hESC	organoids	per	panel	and	per	condition.	 Images	 are	 representative	 of	 a	 minimum	 of	 2	 independent	experiments	per	panel.			
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Methods	
Ethics	Statement		Human	 embryo	 experiments	 were	 performed	 in	 three	 different	 groups	 under	three	different	 licenses	obtained	from	the	Human	Fertilization	and	Embryology	Authority	(HFEA):	-	License	reference	R0193-1-a	(University	of	Cambridge):	Cryopreserved	human	embryos	were	donated	to	this	project,	entitled	“Filming	of	human	implantation	in	vitro”,	after	an	informed	consent	of	couples	undergoing	IVF	treatments.	Prior	to	 giving	 consent	 persons	 donating	 embryos	 were	 provided	 with	 all	 the	necessary	 information	 about	 the	 research	 project	 and	 conditions	 that	 apply	within	the	license	and	HFEA	Code	of	Practice.	In	addition,	an	independent	ethic	approval	was	obtained	from	the	“Human	Biology	Research	Ethics	Committee”	of	the	University	of	Cambridge.		-	 License	 reference	 R0075	 (Kings	 College	 London,	 Guy’s	 Hospital):	 Informed	consent	was	 obtained	 from	all	 subjects	 and	 the	 experiments	 conformed	 to	 the	principles	 set	 out	 in	 the	 WMA	 Declaration	 of	 Helsinki	 and	 the	 NIH	 Belmont	Report.	No	financial	inducements	are	offered	for	donation.	This	project	has	also	a	local	 ethical	 approval	 (UK	 National	 Health	 Service	 Research	 Ethics	 Committee	Reference:	06/Q0702/90).		-	 License	 reference	R0162	 (The	Francis	Crick	 Institute):	 Informed	consent	was	obtained	from	all	couples	that	donated	spare	embryos	following	IVF	treatment.	Prior	to	giving	consent	persons	donating	embryos	were	provided	with	all	of	the	necessary	 information	 about	 the	 research	 project,	 an	 opportunity	 to	 receive	counseling	and	the	conditions	that	apply	within	the	license	and	the	HFEA	Code	of	Practice.	No	financial	inducements	are	offered	for	donation.	This	project	also	has	ethical	 approval	 from	 the	 UK	 National	 Health	 Services	 Research	 Ethics	Committee	Reference:	04/Q0108/99.		In	 the	 three	 locations	 involved	 in	 this	 project,	 all	 the	 experiments	 on	 human	embryos	 were	 performed	 under	 the	 HFEA	 Codes	 of	 Practice	 and	 the	 Human	Fertilization	 and	 Embryology	 Act	 1990	 practices.	 Human	 embryos	 were	 not	maintained	in	culture	past	14	days	or	appearance	of	the	primitive	streak.	
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Human	embryonic	stem	cell	work	complies	the	regulations	of	the	and	UK	Code	of	Practice	 for	 the	Use	of	Human	Stem	Cell	Lines	and	UK	Stem	Cell	Bank	Steering	committee.	An	ethical	approval	for	this	project	was	obtained	from	the	UK	Stem	Cell	Steering	Committee.		
Human	embryo	thawing	and	zona	pellucida	removal		Human	 blastocysts	 (day	 5	 and	 day	 6),	 were	 thawed	 using	 Kitazato	 Thawing	Media	 Kit	 VT802	 (91182;	 Kitazato	 Dibimed;	 Shizuoka,	 Japan),	 or	 Quinn’s	Advantage®	 Thaw	 Kit	 (ART-8016;	 LifeGlobal®Group;	 Guelph,	 Canada)	depending	 on	 the	 protocol	 used	 for	 freezing	 and	 following	 the	manufacturer’s	instructions.	Cleavage	stage	embryos	(day	1,	day	2	and	day	3)	were	thawed	using	Embryo	 Thawing	 Pack	 (10984010;	 Origio;	 Malov,	 Denmark)	 and	 cultured	 in	drops	of	human	embryo	culture	medium	(LGGG-020;	LifeGlobal®Group;	Guelph,	Canada)	 supplemented	 with	 10%	 (vol/vol)	 protein	 supplement	 (LPGS-605; LifeGlobal®Group;	 Guelph,	 Canada)	 under	mineral	 oil	 (9305;	 Irvine	 Scientific;	California,	US)	until	blastocyst	stage.	The	zona	pellucida	of	each	blastocyst-stage	embryo	 was	 removed	 by	 brief	 exposure	 to	 Acidic	 Tyrode’s	 solution	 (T1788;	Sigma-Aldrich;	 St.	 Louis,	 US),	 embryos	 were	 washed	 in	 the	 human	 embryo	culture	 medium	 (LGGG-020;	 LifeGlobal®Group;	 Guelph,	 Canada),	 or	 SAGE	 1-Step™	 (67010060A;	 LifeGlobal®Group;	 Guelph,	 Canada)	 and	 transferred	 to	 in	
vitro	culture	medium	(see	below).			
Human	embryo	in	vitro	culture	from	pre-	to	post-implantation	stage	The	 in	 vitro	 culture	 procedure	 is	 illustrated	 in	 Figure	 1a.	 Day	 5-6	 human	blastocysts	 devoid	 of	 zona	pellucida	 were	 cultured	 on	 8-well	 IbiTreat	 μ-plates	(IB-80826;	 Ibidi	 GmbH;	 Martinsried,	 Germany)	 with	 in	 vitro	 culture	 media	 at	37°C,	in	21%	O2/5%	CO2	or	when	indicated	in	5%	O2/5%	CO2.	For	the	first	48	h	the	embryos	were	cultured	in	 in	vitro	culture	medium	1	(IVC1;	see	below)7.	On	the	in	vitro	culture	day	2	(embryo	day	7-8	post	fertilization),	50%	of	the	culture	medium	was	 replaced	 with	 the	 in	 vitro	 culture	 medium	 2	 (IVC2;	 see	 below)7.	From	 in	 vitro	 culture	 day	 3	 on,	 IVC2	 medium	 was	 used	 and	 medium	 was	refreshed	 on	 daily	 basis.	 Two	 alternative	 IVC2	 compositions	 were	 used.	 The	detailed	composition	of	the	media	used	is	outlined	below:	
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- IVC1:	 Advanced	 DMEM/F12	 (12634-010;	 Thermo	 Fischer	 Scientific;	Waltham,	 US)	 supplemented	 with	 20%	 (vol/vol)	 heat-inactivated	 FBS	(Produced	in	house,	Stem	Cell	Institute,	the	University	of	Cambridge,	UK;	or	 35-015-CV;	 Corning;	 New	 York,	 US),	 2mM	 L-Glutamine	 (25030;	Thermo	 Fisher	 Scientific;	 Waltham,	 US),	 penicillin	 (25	units/ml)/Streptomycin	 (25	 μ g/ml)	 (15070-063;	 Thermo	 Fischer	Scientific;	Waltham,	US),	1X	ITS-X	(10	mg/L	insulin	,	5.5	mg/L	transferrin,	0.0067	mg/L	 sodium	 selenite,	 2	mg/L	 etholamine;	 51500-056;	 Thermo	Fisher	Scientific;	Waltham,	US),	8	nM	β-estradiol	(E8875;	Sigma-Aldrich;	St.	Louis,	US),	200	ng/ml	progesterone	(P0130;	Sigma-Aldrich;	St.	Louis,	US)	and	25	μM	N-acetyl-L-cysteine	(A7250;	Sigma-Aldrich;	St.	Louis,	US).	- Defined	 IVC2:	 Advanced	DMEM/F12,	 supplemented	with	 30%	 (vol/vol)	KnockOut	 Serum	 Replacement	 (10828010;	 Thermo	 Fisher	 Scientific;	Waltham,	US),	2	mM	L-Glutamine,	Penicillin	(25	units/ml)/Streptomycin	(25	μg/ml),	1X	 ITS-X,	8	nM	β-estradiol,	200	nG/mL	progesterone,	and	25	μM	N-acetyl-L-cysteine.	 The	 same	 catalogue	 numbers	 and	 suppliers	apply	as	above.		- Non-defined	 IVC2:	 Advanced	 DMEM/F12,	 supplemented	 with	 20%	(vol/vol)	Human	cord	serum	(Addenbrookes	Hospital,	Cambridge,	UK),	2	mM	L-Glutamine,	Penicillin	 (25	units/ml)/Streptomycin	(25	μg/ml),	1X	ITS-X,	8	nM	β-estradiol,	200	nG/mL	progesterone,	and	25	μM	N-acetyl-
L-cysteine.	The	same	catalogue	numbers	and	suppliers	apply	as	above.		A	 step-by-step	 protocol	 of	 the	 in	 vitro	 culture	 of	 human	 embryos	 through	implantation	stages	can	be	found	at	Nature	Protocol	Exchange34.		
Human	embryo	time-lapse	imaging		Time-lapse	 phase	 contrast	 images	 were	 acquired	 using	 spinning	 disc	 confocal	microscopy	 (3i	 Intelligent	 Imaging	 Innovations)	 and	 a	 Zeiss	 0.55	 NA	 20X	 (EC	PlnN)	objective;	and	wide	field	microscopy	(3i	 Intelligent	 Imaging	Innovations)	and	 a	 	 Zeiss	 Plan-Apo	 Chromat	 0.75	 NA	 20X	 objective	 .	 The	 embryos	 were	imaged	 in	 humidified	 21%	 O2.	 Z-range	 of	 120	 μm	 with	 5	 μm	 intervals	 were	
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scanned	 in	 every	 30	 min.	 The	 images	 were	 processed	 using	 Fiji	(http://fiji.sc/Fiji).			
Immunofluorescence	of	human	embryos	Embryos	 were	 fixed	 with	 4%	 paraformaldehyde	 (PFA)	 for	 20	 min	 at	 room	temperature,	washed	with	phosphate	buffered	 saline	 (PBS),	 and	permeabilized	by	 0.5%	Triton	 X-100	 in	 PBS	 at	 room	 temperature	 for	 20	min.	 Embryos	were	blocked	 with	 10%	 FBS	 (Produced	 in	 house,	 Stem	 Cell	 Institute,	 Cambridge,	UK)/3%	(w/vol)	bovine	serum	albumin	(A3311;	Sigma-Aldrich,	St.	Louis,	US)	in	PBS,	at	room	temperature	for	4	hrs.	The	primary	antibodies	mouse	monoclonal	anti-Oct3/4	(C-10;	sc-5279;	Santa	Cruz	Biotechnology;	Dallas,	US;	1:200),	rabbit	polyclonal	anti-aPKC	(C-20;	Sc-216;	Santa	Cruz	Biotechnology;	Dallas,	US;	1:200),	goat	 monoclonal	 anti-GATA6	 (clone	 222228;	 mab1700;	 R&D	 Systems;	Minneapolis,	US;	1:200),	rabbit	polyclonal	anti-PARD6B	(M-64;	sc-67393;	Santa	Cruz	Biotechnology;	Dallas,	US;	1:200)	and	mouse	monoclonal	anti-Cytokeratin	7	(OVTL	 12-30;	 sc-52322;	 Santa	 Cruz	 Biotechnology;	 Dallas,	 US;	 1:200)	 were	diluted	in	3%	(w/vol)	bovine	serum	albumin	(as	above)/0.1%	Tween20	(P9416;	Sigma	Aldrich;	St.Louis,	US)	in	PBS	and	incubated	at	4°C	for	over	night.	Samples	were	 incubated	 with	 the	 following	 fluorescence-conjugated	 secondary	antibodies:	 donkey	 anti-mouse	 AlexaFluor®568,	 donkey	 anti-rabbit	AlexaFluor®647,	 donkey	 anti-goat	 AlexaFluor®488	 from	 Thermo	 Fisher	Scientific;	 Waltham,	 US.	 All	 secondary	 antibodies	 were	 diluted	 1:500	 in	 3%	(w/vol)	 bovine	 serum	 albumin	 (as	 above)/0.1%	 Tween20	 (P9416;	 Sigma	Aldrich;	 St.Louis,	 US)	 in	 PBS.	 F-actin	 was	 stained	 with	 AlexaFluor®488	Phalloidin	 (A12379;	 Thermo	 Fisher	 Scientific;	Waltham,	 US;	 1:200)	 and	 nuclei	were	stained	with	DAPI	(D3571;	Thermo	Fisher	Scientific;	Waltham,	US;	1;1000).			
Human	pluripotent	stem	cell	culture		hESC	 line	H9	and	hiPSC	 line	FSPS	13B	 	were	kindly	provided	by	Prof.	 Ludovic	Vallier	 (Stem	 Cell	 Institute,	 Anne	 McLaren	 Laboratory,	 Cambridge,	 UK).	 The	hiPSC	line	SC101A-1	(System	Biosciences)31	was	kindly	provided	by	Dr.	Madeline	Lancaster	(MRC	Laboratory	of	Molecular	Biology,	Cambridge,	UK).	These	hPSCs	were	maintained	on	Geltrex	(A15696-01;	Thermo	Fisher	Scientific;	Waltham,	US)	
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–coated	culture	plates	in	complete	serum-free	defined	hPSC	culture	media,	either	Essential	8	(E8;	A1517001;	Thermo	Fisher	Scientific;	Waltham,	US)	or	mTeSR™1	(05850;	Stem	Cell	Technologies;	Vancouver,	Canada).	Authentication	of	 the	cell	lines	was	done	based	on	pluripotent	gene	expression.	No	cell	 lines	used	 in	 this	study	were	 found	 in	 the	 database	 of	 commonly	misidentified	 cell	 lines	 that	 is	maintained	by	ICLAC	and	NCBI	Biosample	and	they	were	not	routinely	tested	for	mycoplasma.			
3D	culture	of	hPSCs	hPSCs	were	suspended	as	single	cells	using	StemPro	Accutase	Cell	Dissociation	Reagent	(A11105-1;	Thermo	Fisher	Scientific;	Waltham,	US)	and	plated	following	a	 3D	 on	 top	 protocol	 as	 previously	 described32.	 Briefly,	 IbiTreatμ-plates	 (IB-80826;	Ibidi	GmbH;	Martinsried,	Germany)	were	coated	with	Matrigel	Basement	Membrane	Growth	Factor	Reduced	(354230;	Corning;	New	York,	US)	and	2×104	cells	 were	 plated	 in	 either	 E8	 or	 mTeSR™1	 medium.	 After	 5	 min	 and	 upon	attachment	 of	 the	 cells	 to	 the	 matrigel	 layer,	 the	 medium	 was	 removed	 and	either	fresh	E8	or	mTeSR™1	medium	supplemented	with	5%	Matrigel	was	added	on	top.	When	indicated,	10	μM	ROCK	inhibitor	Y-27632	(Y0503;	Sigma-Aldrich;	St.	Louis,	US)	or	10/20	μM	Caspase	3	inhibitor	Z-DEVD-FMK	(1143-5;	BioVision;	Milpitas,	US)	were	added	to	the	medium.	A	 step-by-step	 protocol	 of	 the	 3D	 culture	 of	 hPSCs	 can	 be	 found	 at	 Nature	Protocol	Exchange34.		
Immunofluorescence	of	3D	cultured	hPSCs	hPSCs	 embedded	 in	 Matrigel	 were	 fixed	 with	 either	 4%	 PFA	 at	 room	temperature	 or	 ice-cold	 methanol	 at	 -20°C	 for	 15	 min.	 	 The	 samples	 were	permeabilized	with	0.3%	Tx100	–	0.1	M	glycine	in	PBS	for	20	min.	The	primary	antibodies	mouse	monoclonal	 anti-Oct3/4	 (as	 above,	 1:200),	 rabbit	 polyclonal	anti-aPKC	 (as	 above,	 1:200),	 rabbit	 polyclonal	 anti-PARD6B	 (as	 above,	 1:200),	mouse	monoclonal	anti-GM130	(clone	35/GM130;	610822;	BD	Biosciences;	San	Jose,	 US;	 1:200),	 	 mouse	 monoclonal	 anti−γ−tubulin	 (clone	 GTU-88;	 T5326; Sigma,	 St.Louis,	 US;	 1:500)	 and	mouse	monoclonal	 anti-PODXL	 (clone	 222328;	MAB1658;	 R&D	 Systems;	 Minneapolis,	 US;	 1:200)	 were	 diluted	 in	 	 blocking	
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buffer	 (1%	Bovine	 Serum	Albumin	–	A3311;	 Sigma-Aldrich;	 St.	 Louis,	US	 -	 and	0.1%	Tween)	and	incubated	at	4°C	over	night.	Samples	were	washed	three	times	with	 PBS-0.1%	 Tween	 and	 incubated	 with	 AlexaFluor®-conjugated	 secondary	antibodies	(as	above).			
Imaging		The	 images	 of	 the	 fixed	 samples	 were	 acquired	 using	 inverted	 SP5	 confocal	microscope	(Leica	Microsystems,	Manheim,	Germany)	and	Leica	1.3	NA	40X	oil	(HC	PL	APO),	Leica	1.4	NA	63X	oil	 (HC	PL	APO)	and	Leica	1.3	NA	63x	glycerol	(HCX	PL	APO)	 objectives.	 The	 images	were	processed	using	 Fiji	 (http://fiji.sc),	Chimera	(https://www.cgl.ucsf.edu/chimera/)	and	MovIT	visualization	software	(BioEmergences,	http://bioemergences.iscpif.fr/)33.			
Statistics	and	reproducibility	The	exact	number	of	embryos	analysed	in	the	different	conditions,	as	well	as	the	number	 of	 embryos	 that	 displayed	 a	 polarized	 epiblast	 is	 indicated	 in	Supplementary	Table	1.		No	statistical	method	was	used	to	predetermine	sample	size.	Given	the	nature	of	the	 work	 (mostly	 descriptive)	 no	 statistical	 comparisons	 were	 done	 between	different	 embryos.	 	 Embryos	 that	 showed	 abnormalities	 (fragmented	blastomeres	or	developmentally	arrested)	were	excluded	from	the	analysis.	The	investigators	 were	 not	 blinded	 to	 allocation	 during	 experiments	 and	 outcome	assessment.		Figure	1	involved	the	assessment	of	5	embryos	out	of	which	3	showed	a	correct	development.	These	data	is	representative	of	3	independent	experiments.	Figure	2	involved	the	assessment	of	20	embryos	cultured	in	5%	O2,	out	of	which	all	of	them	lacked	the	pluripotent	lineage	(phenotype	shown	in	the	image).	These	data	 is	 representative	 of	 3	 independent	 experiments.	 Embryos	were	 randomly	assigned	to	either	5%	O2	or	21%	O2.	Figures	 3	 and	 4	 involved	 the	 assessment	 of	 59	 embryos.	 Briefly,	 29	 embryos	preserved	a	cluster	of	pluripotent	cells;	and	out	of	 these	29	embryos,	9	had	an	organized	epiblast.	These	data	is	representative	of	6	independent	experiments.	
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Figures	5	and	6	involved	the	assessment	of	a	minimum	of	10	hPSC	organoids	per	experiment.	 These	 data	 is	 representative	 of	 a	 minimum	 of	 2	 independent	experiments	per	panel.		Qualitative	 data	 is	 presented	 in	 the	 form	of	 a	 contingency	 table	 (Fig.	 6h).	 This	data	was	analyzed	using	a	Fisher’s	exact	test.		Quantitative	data	 is	 presented	 as	mean	±	 s.e.m.	The	normality	 of	 the	data	was	analyzed	with	 a	 D’Agostino&Pearson	 normality	 test.	 Data	 presented	 in	 Fig.	 5b	displayed	a	normal	distribution	with	 significantly	different	variances.	This	was	analyzed	using	an	unpaired	two-tailed	Student’s	t	test	with	a	Welch’s	correction.		31.	 Lancaster,	M.A.	et	al.	Cerebral	organoids	model	human	brain	development	and	microcephaly.	Nature	501,	373-379	(2013).	32.	 Lee,	 G.Y.,	 Kenny,	 P.A.,	 Lee,	 E.H.	&	Bissell,	M.J.	 Three-dimensional	 culture	models	 of	 normal	 and	malignant	 breast	 epithelial	 cells.	Nat	Methods	 4,	359-365	(2007).	33.	 Faure,	 E.	 et	 al.	 A	 workflow	 to	 process	 3D+time	 microscopy	 images	 of	developing	organisms	and	reconstruct	 their	 cell	 lineage.	Nat	Commun	7,	8674	(2016).	34.	 	 	 	 	 Vuoristo,	 S.,	 Jedrusik,	 A.,	 Shahbazi,	M.N.	&	 Zernicka-Goetz,	M.	 Culture	 of	human	embryos	through	implantation	stages	in	vitro.	Protocol	Exchange.	(2016).		
Supplementary	figure	legends	
	
Supplementary	Video	1:	Development	of	a	day	5	human	blastocyst	in	the	in	
vitro	 culture	 system	 up	 to	 day	 9-10.	 Related	 to	 Figure	 1.	 A	 day	 5	 human	embryo	was	 cultured	 in	 the	 in	vitro	 culture	 system	 for	 approximately	100	hrs.	Bright	 field	 images	were	 taken	 every	 30	min	 to	 record	 its	 development.	 Scale	bar,	100	μm.		
	
Supplementary	Video	2:	Development	of	a	day	9	human	blastocyst	in	the	in	
vitro	culture	system	up	to	day	12.	Related	to	Figure	1.	A	day	9	human	embryo	was	cultured	in	the	in	vitro	culture	system	for	approximately	72	hrs.	Bright	field	images	were	taken	every	30	min	to	record	its	development.	Scale	bar,	100	μm.			
Supplementary	Video	3:	3D	reconstruction	of	embryonic	lineages	in	a	day	
9-10	human	embryo	cultured	in	vitro.	Related	to	Figure	3.	Nuclei	are	shown	in	blue,	OCT4	in	grey	and	GATA6/F-actin	in	green.		
	
Supplementary	Video	4:	3D	reconstruction	of	embryonic	lineages	in	a	day	
10-11	human	embryo	cultured	in	vitro.	Related	to	Figure	3.	Nuclei	are	shown	in	blue,	OCT4	in	grey	and	GATA6/F-actin	in	green.		
	
Supplementary	 Video	 5:	 3D	 reconstruction	 of	 the	 cellular	 and	 nuclear	
shape	of	representative	trophectoderm	cells	at	day	10-11.	Related	to	Figure	3.	Nuclei	are	shown	in	magenta	and	membranes	in	green.	Note	that	cells	in	close	proximity	to	the	epiblast	have	a	single	nucleus,	whereas	cells	in	the	periphery	of	the	embryo	are	multinucleated.		
Supplementary	 Video	 6:	 3D	 reconstruction	 of	 the	 pro-amniotic	 cavity	 at	
day	 9-10.	 Related	 to	 Figure	 4.	 The	 nuclei	 of	 OCT4-expressing	 epiblast	 cells	 is	shown	in	grey	and	the	pro-amniotic	cavity	in	red.		
Supplementary	 Video	 7:	 3D	 reconstruction	 of	 the	 cellular	 shape	 of	
representative	 OCT4-expressing	 epiblast	 cells	 at	 day	 10-11.	 Related	 to	
Figure	4.	 Epiblast	 cells	 in	 close	proximity	 to	GATA6-expressing	hypoblast	 cells	are	 shown	 in	green	 (note	 the	 columnar	 shape	characteristic	of	 cells	within	 the	epiblast	disc).	Epiblast	cells	in	close	proximity	to	cytotrophoblast	cells	are	shown	in	magenta	(note	the	squamous	shape	characteristic	of	amniotic	cells).			
Supplementary	Video	 8:	 3D	 reconstruction	 of	 the	 prospective	 yolk	 sac	 at	
day	10-11.	Related	to	Figure	4.	The	nuclei	of	OCT4-expressing	epiblast	cells	 is	shown	in	grey	and	the	prospective	yolk	sac	in	blue.		
Supplementary	Video	9:	 3D	 reconstruction	 of	 the	 hypoblast	 derived	 cells	
and	 their	 position	with	 respect	 to	 the	 prospective	 yolk	 sac	 at	 day	 10-11.	Related	to	Figure	4.	Nuclei	of	OCT4-expressing	epiblast	cells	are	shown	in	grey,	GATA6/F-actin	is	shown	in	green	and	the	prospective	yolk	sac	in	blue.	
	
Supplementary	 Figure	 1:	 3D	 analysis	 of	 embryonic	 and	 extra-embryonic	
lineages	 in	human	embryos	cultured	through	 implantation	stages.	Related	to	Figures	3	and	4.	Human	blastocysts	developing	in	vitro	until	day	11	were	fixed	and	stained	at	indicated	time	points.		a,	3D	rendering	of	DAPI	stain	overlaid	with	the	centre	of	OCT4-expressing	and	GATA6-expressing	cells.	Dots	are	projected	at	the	 back	 of	 the	 volume.	 b,	 Orthogonal	 views	 of	 embryos	 at	 different	developmental	stages	stained	 for	aPKC	and	OCT4.	Note	the	presence	of	a	small	pro-amniotic	cavity	at	day	8-9,	which	 is	enlarged	as	development	proceeds.	All	scale	bar,	50	μm.		
Supplementary	Figure	2:	Confocal	Z-sections	of	a	day	7-8	human	embryo.	Related	to	Figure	4.	Day	7-8	human	embryo	stained	for	OCT4,	aPKC	and	F-actin.	The	different	images	correspond	to	representative	confocal	Z	sections.	Scale	bar,	20	μm.		Boxes	indicate	the	magnified	area	(scale	bar,	10	μm).			
Supplementary	Figure	3:	Confocal	Z-sections	of	a	day	8-9	human	embryo.	Related	to	Figure	4.	Day	8-9	human	embryo	stained	for	OCT4,	aPKC	and	F-actin.	The	 different	 images	 correspond	 to	 representative	 confocal	 Z	 sections.	 The	arrow	 indicates	 the	presence	of	 a	 lumen.	 Scale	bar,	 20	μm.		Boxes	 indicate	 the	
magnified	area	(scale	bar,	10	μm).		
Supplementary	Figure	4:	Confocal	Z-sections	of	a	day	9-10	human	embryo.	Related	to	Figure	4.	Day	9-10	human	embryo	stained	for	OCT4,	aPKC	and	F-actin.	The	 different	 images	 correspond	 to	 representative	 confocal	 Z	 sections.	 The	arrow	indicates	the	presence	of	a	lumen	surrounded	by	radially	organised	OCT4-expressing	 epiblast	 cells.	 Scale	 bar,	 20	 μm.		 Boxes	 indicate	 the	magnified	 area	(scale	bar,	10	μm).		
Supplementary	Figure	5:	Confocal	Z-sections	of	a	day	10-11	human	embryo.	Related	 to	 Figure	 4.	 Day	 10-11	 human	 embryo	 stained	 for	 OCT4,	 aPKC	 and	 F-actin.	The	different	images	correspond	to	representative	confocal	Z	sections.	The	arrow	indicates	the	presence	of	a	small	lumen	surrounded	by	radially	organised	OCT4-expressing	epiblast	 cells.	 Scale	bar,	50	μm.		Boxes	 indicate	 the	magnified	area	(scale	bar,	20	μm).		
Supplementary	 Table	 1:	 Summary	 of	 human	 embryos	 cultured	 in	 this	 study.	Note	the	lack	of	epiblast	lineage	in	embryos	cultured	in	hypoxic	conditions.	
	
Supplementary	 Table	 2:	 Average	 number	 of	 epiblast	 and	 hypoblast	 cells	 in	human	embryos	at	different	stages	of	implantation	development	in	vitro.					
